News

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
UK regulators on Tuesday fined 23andMe 2.31 million pounds ($3.1 million) for data privacy violations stemming from the ...
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...
The genetic testing company 23andMe is being fined £2.31m by the UK's privacy watchdog over their 2023 data breach ...
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
The ICO has fined genetic testing company 23andMe £2.31 million. It is related to a data breach that impacted the data of 155,592 UK users. The company ...
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
Me was fined £2.31 million ($3.1 million) by UK regulators after a 2023 cyber attack exposed users’ genetic data in yet ...